⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Homozygous Familial Hypercholesterolemia (HoFH) - 7MM Market, Epidemiology, and Forecast - 2036 | RNAi and Targeted Therapies Expand Uptake and Investment Opportunities
globenewswire.com
AMGN
CHRS
ARWR
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)
globenewswire.com
TEVA
AMGN
United Kingdom NOR Flash Market (2026-2031) - ADAS and EV Platform Adoption Drives Growth
globenewswire.com
IFNNY
MU
WBD
MX
CHKP
ADI
NXPI
STX
AMAT
ASML
KLAC
TER
ADSK
CDNS
SNPS
MRVL
NVDA
AMD
INTC
QCOM
TXN
MCHP
ON
STM
AEHR
AMBA
ALGN
ADBE
ACGL
AEP
AMGN
AMZN
AAPL
AVGO
BIIB
BKNG
BKR
CDW
CEG
CHTR
CMCSA
COST
CRWD
CSCO
CTAS
DDOG
DELL
DLTR
DOX
DXCM
EA
EBAY
EXC
FAST
FIS
FTNT
FTV
GILD
GOOG
GOOGL
HON
IBM
IDXX
ILMN
INTU
ISRG
JD
KDP
KHC
LRCX
LULU
MAR
MDT
MELI
META
MNST
MRNA
MSFT
NFLX
ORLY
PANW
PAYX
PCAR
PEP
PFE
PLTR
PM
POOL
PPC
PSA
REGN
ROST
SBUX
SIRI
SWKS
SYK
TCOM
TEAM
TGT
TMO
TMUS
TSLA
ULTA
VRSK
VRTX
WDAY
WDC
XEL
XOM
ZBRA
KRAS Inhibitor Market Projected to Reach $7.8 Billion by 2034
prnewswire.com
LLY
RVMD
ONCY
AMGN
VSTM
Global Cyclic Peptide Library Market Outlook and Forecast, 2026-2032 - AI-Enabled Discovery Fuels 16.32% CAGR Toward USD 9.86 Billion as PeptiDream, Bicycle Therapeutics, Pfizer and Roche Advance Competition
globenewswire.com
PFE
AMGN
AZN
EVTC
MRK
NVS
Keystone To Launch India Business With Bengaluru As First Hub, Plans To Hire Talent & Increase Workforce Over Next Two Years
prnewswire.com
MSFT
META
AMZN
GS
AMGN
Point-of-Care Molecular Diagnostics Market Poised for Growth Through 2029 as Rapid, Decentralized Testing Drives Opportunities Across Applications, Technologies, Products and Countries
globenewswire.com
ABT
AMGN
DHR
PFE
QGEN
TMO
Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research
prnewswire.com
ABBV
JNJ
AMGN
BMY
PFE
NVS
SNY
LLY
AZN
UCB
BIIB
VTRS
GILD
KYMR
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
prnewswire.com
NVS
BIIB
SNY
MRK
BMY
JNJ
TEVA
VTRS
AMGN
Oncology Clinical Trials Market Set for Strong Growth Through 2035, Fueled by Precision Medicine, Immunotherapy and Decentralized Trial Innovation
globenewswire.com
AZN
MRK
NVS
LRCX
NVDA
GOOG
MSFT
AMGN
BMY
JNJ
PFE
LLY
ABBV
IQV
ICLR
LH
TMO